NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Neurosoft Bioelectronics

Neurosoft Bioelectronics

Private
GenevaHealthcare & Life Scienceshttps://www.neurosoft-bio.com/

Last Round

Seed

May 20, 2026

Total Funding Raised

$18.4M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Neurosoft Bioelectronics is a neurotechnology company that develops and manufactures soft, elastic, and minimally invasive brain-computer interfaces (BCIs) and neural implants to monitor, treat, and restore neurological functions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Sensors, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Data as a Service, Government Contracts

AI Layer

Application

Keywords

brain-computer interfaceBCIsoft electrodesimplantable electrodesneurotechnologybrain implantsneural interfaceneuromodulationepilepsy treatmentminimally invasiveneural recordingtinnitus treatmentsubdural electrodesmedical devicesneural data platformneural foundation model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neurosoft Bioelectronics Comparables

Compare Neurosoft Bioelectronics with similar companies based on industry and business-model similarity.

Neurosoft Bioelectronics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Neurosoft Bioelectronics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 20, 2026
SeedMay 20, 2024
GrantApr 5, 2022
Convertible DebtDec 17, 2021
GrantJan 28, 2021
Grant
Feb 26, 2020

Key People

Founding team and executive leadership

Florian Fallegger

Chief Scientific Officer And Co-Founder

Founding Team

Ludovic Serex

COO And Co-Founder

Founding Team

Nicolas Vachicouras

CEO & Co-Founder

Founding Team

Neurosoft Bioelectronics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    $8M round led by Skybound Venture Capital

  • Feb 16, 2026

    Grew 58% QoQ, from 12 to 19 employees.

Neurosoft Bioelectronics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neurosoft Bioelectronics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neurosoft Bioelectronics's valuation, stock price, and market status.

Firmographic Details

HeadquartersGeneva
Employee Range19
Year Founded2019
Last FundingMay 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.